Haibo Wu
- Molecular Biology top 10%
- Infectious Diseases top 5%
- Cancer Research top 10%
- Immunology top 10%
- Genetics top 10%
- Co-authors
- Beibei FuJiamin ZhaoJingcheng ZhangXiaoyuan LinWei PengWeiwei XueSongna YinYongsheng Wang
- Topics
- SARS-CoV-2 and COVID-19 Research (12 papers)MicroRNA in disease regulation (9 papers)CRISPR and Genetic Engineering (7 papers)
In The Last Decade
Haibo Wu
93 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 1.2k
- Infectious Diseases 474
- Cancer Research 273
- Immunology 268
- Genetics 267
Countries citing papers authored by Haibo Wu
This map shows the geographic impact of Haibo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Wu more than expected).
Fields of papers citing papers by Haibo Wu
This network shows the impact of papers produced by Haibo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Wu. The network helps show where Haibo Wu may publish in the future.
Co-authorship network of co-authors of Haibo Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Wu. A scholar is included among the top collaborators of Haibo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Wu. Haibo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 8 | |
| 10 | 10 | |
| 11 | 7 | |
| 12 | 1 | |
| 13 | 47 | |
| 14 | Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53 | 2 |
| 15 | 24 | |
| 16 | 18 | |
| 17 | 1 | |
| 18 | 11 | |
| 19 | 132 | |
| 20 | 17 |
About Haibo Wu
Haibo Wu is a scholar working on Virology, Aging and Cancer Research, having authored 100 papers that have together received 2.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), MicroRNA in disease regulation (9 papers) and CRISPR and Genetic Engineering (7 papers). The work is most often cited by research in Geriatrics and Gerontology (154 citations), Aging (53 citations) and Infectious Diseases (474 citations). Haibo Wu has collaborated with scholars based in China, Germany and Egypt. Frequent co-authors include Beibei Fu, Jiamin Zhao, Jingcheng Zhang, Xiaoyuan Lin, Wei Peng, Weiwei Xue, Songna Yin, Yongsheng Wang, Yong Zhang and Na Xing. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.